David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.27% |
| 2 | Consumer Discretionary | 13.7% |
| 3 | Healthcare | 13.3% |
| 4 | Industrials | 7.34% |
| 5 | Financials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVNS
1076
DELISTED
Avanos Medical
AVNS
| $10.5M | 0.01% |
241,338
-146,265
| -38% | -$6.26M |
|
1077
PUT
Capri Holdings
CPRI
$1.52B
| $10.5M | 0.01% |
302,200
+139,000
| +85% | +$5.65M |
|
1078
PUT
Veeva Systems
VEEV
$40.1B
| $10.5M | 0.01% |
64,600
+49,500
| +328% | +$7.21M |
|
1079
SPX Corp
SPXC
$10.2B
| $10.5M | 0.01% |
316,798
-135,889
| -30% | -$4.54M |
|
1080
PUT
Lear
LEA
$8.27B
| $10.5M | 0.01% |
75,100
+27,100
| +56% | +$3.8M |
|
1081
Haemonetics
HAE
$4.93B
| $10.5M | 0.01% |
86,852
-183,756
| -68% | -$18.1M |
|
1082
PUT
Okta
OKTA
$22.8B
| $10.4M | 0.01% |
84,500
+46,500
| +122% | +$5.05M |
|
|
WCG
1083
DELISTED
Wellcare Health Plans, Inc.
WCG
| $10.4M | 0.01% |
36,609
-9,273
| -20% | -$2.56M |
|
|
CHX
1084
DELISTED
ChampionX
CHX
| $10.4M | 0.01% |
310,455
+201,664
| +185% | +$7.32M |
|
|
TMHC
1085
DELISTED
Taylor Morrison
TMHC
| $10.4M | 0.01% |
496,745
-172,772
| -26% | -$3.44M |
|
1086
Deckers Outdoor
DECK
$12.1B
| $10.4M | 0.01% |
354,876
-92,106
| -21% | -$2.39M |
|
1087
CBIZ
CBZ
$2.96B
| $10.4M | 0.01% |
530,504
+61,167
| +13% | +$1.23M |
|
1088
Grand Canyon Education
LOPE
$3.82B
| $10.4M | 0.01% |
88,699
-167,418
| -65% | -$20M |
|
|
BHVN
1089
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $10.4M | 0.01% |
236,916
+197,879
| +507% | +$11.2M |
|
|
MRSH
1090
Marsh
MRSH
$92.9B
| $10.4M | 0.01% |
103,790
+62,463
| +151% | +$5.98M |
|
1091
Adtran
ADTN
$645M
| $10.3M | 0.01% |
678,228
+248,296
| +58% | +$3.96M |
|
1092
COPT Defense Properties
CDP
$4.24B
| $10.3M | 0.01% |
391,122
-175,808
| -31% | -$4.9M |
|
1093
PUT
Viatris
VTRS
$19.1B
| $10.3M | 0.01% |
541,200
+258,400
| +91% | +$5.71M |
|
1094
V2X
VVX
$2.42B
| $10.2M | 0.01% |
251,955
-14,406
| -5% | -$529K |
|
|
AMAG
1095
DELISTED
AMAG Pharmaceuticals
AMAG
| $10.2M | 0.01% |
1,022,054
-15,705
| -2% | -$169K |
|
1096
Charter Communications
CHTR
$18.4B
| $10.2M | 0.01% |
25,787
+2,130
| +9% | +$798K |
|
1097
Belden
BDC
$4.58B
| $10.2M | 0.01% |
170,898
-9,250
| -5% | -$531K |
|
|
SIVB
1098
DELISTED
SVB Financial Group
SIVB
| $10.2M | 0.01% |
45,292
-58,636
| -56% | -$13.6M |
|
|
SFIX
1099
Stitch Fix
SFIX
$430M
| $10.2M | 0.01% |
317,892
-391,072
| -55% | -$10.5M |
|
|
PDCE
1100
DELISTED
PDC Energy, Inc.
PDCE
| $10.2M | 0.01% |
281,714
+240,717
| +587% | +$9.08M |
|
Similar funds
David Shaw's Q2 2019 Portfolio in Review
As of Q2 2019, David Shaw held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- David Shaw added most to Alibaba in Q2 2019, an estimated $667M increase.
- David Shaw's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- David Shaw's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- David Shaw opened 499 new positions and closed 416 in Q2 2019.
- David Shaw's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.